# Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study

> **NCT02308124** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 87 (actual)

## Conditions studied

- Orthostatic; Hypotension, Neurogenic

## Interventions

- **DRUG:** Midodrine
- **DRUG:** Pyridostigmine Bromide
- **DRUG:** Midodrine + pyridostigmine

## Key facts

- **NCT ID:** NCT02308124
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2021-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02308124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02308124, "Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02308124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*